What is the possible diagnosis for a patient presenting with syncope, neutrophil-predominant leukocytosis, proteinuria, heavy right renal atrophy, and ground glass opacities on thoracic computed tomography (CT) scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Granulomatosis with Polyangiitis (GPA/Wegener's Granulomatosis)

The constellation of neutrophilic leukocytosis, proteinuria, renal atrophy, and ground glass opacities on thoracic CT in a patient presenting with syncope strongly suggests granulomatosis with polyangiitis (GPA), particularly given the pulmonary-renal syndrome pattern.

Clinical Reasoning

This patient presents with a classic pulmonary-renal syndrome requiring urgent evaluation:

  • Neutrophil-predominant leukocytosis (30,000) with negative CRP is unusual for typical infection but characteristic of systemic vasculitis, where neutrophil activation occurs without proportionate acute phase reactant elevation 1

  • Proteinuria (2+) with normal kidney function suggests active glomerular disease, though the heavy right renal atrophy indicates chronic damage from prior disease activity 2, 3

  • Ground glass opacities at lower basal surfaces on thoracic CT represent alveolar hemorrhage or capillaritis, a hallmark of pulmonary vasculitis 4

  • Syncope in this context likely results from either pulmonary hemorrhage causing hypoxemia, cardiac involvement from vasculitis, or systemic inflammatory effects 4

Differential Diagnosis Considerations

Primary Consideration: ANCA-Associated Vasculitis (GPA)

  • The pulmonary-renal syndrome pattern with neutrophilic leukocytosis is pathognomonic for ANCA-associated vasculitis 1
  • Ground glass opacities in the lower lung fields suggest diffuse alveolar hemorrhage, which occurs in 10-30% of GPA cases 4
  • Unilateral renal atrophy suggests prior focal vasculitic involvement with chronic ischemic damage 3

Alternative Diagnoses to Exclude

Goodpasture syndrome (anti-GBM disease):

  • Also presents with pulmonary-renal syndrome but typically shows more symmetric bilateral ground glass opacities 1
  • Less likely to cause marked neutrophilic leukocytosis
  • Requires anti-GBM antibody testing for differentiation

Systemic lupus erythematosus with lupus nephritis:

  • Can cause proteinuria and pulmonary involvement 4, 1
  • However, neutrophilic leukocytosis of 30,000 would be atypical; lupus more commonly causes leukopenia
  • Ground glass opacities in lupus pneumonitis have different distribution patterns 4

Microscopic polyangiitis:

  • Another ANCA-associated vasculitis that presents similarly 1
  • Clinical distinction from GPA requires tissue biopsy showing granulomatous inflammation in GPA

Urgent Diagnostic Workup Required

Immediate Laboratory Testing

  • ANCA serologies (c-ANCA/PR3 and p-ANCA/MPO) are essential, as 90% of GPA cases are c-ANCA/PR3 positive 1
  • Anti-GBM antibodies to exclude Goodpasture syndrome 1
  • Complement levels (C3, C4) to evaluate for immune complex disease 1
  • Urinalysis with microscopy to assess for dysmorphic red blood cells and red cell casts indicating glomerulonephritis 3, 1
  • Quantitative proteinuria (protein:creatinine ratio) to establish baseline severity 2

Imaging Considerations

  • The thoracic CT findings of ground glass opacities require urgent evaluation, as they may represent life-threatening alveolar hemorrhage 4
  • High-resolution CT (HRCT) with thin sections (1-2mm) can better characterize the ground glass pattern and identify centrilobular nodules or cavitary lesions suggestive of GPA 4
  • Cardiac imaging is not routinely indicated for syncope evaluation unless cardiac etiology is suspected on initial assessment 4

Tissue Diagnosis

  • Kidney biopsy is the gold standard for diagnosing glomerulonephritis and should be performed urgently given proteinuria and concern for rapidly progressive disease 4, 3, 1
  • Expected findings in GPA include pauci-immune necrotizing crescentic glomerulonephritis 1
  • Bronchoscopy with bronchoalveolar lavage should be considered if alveolar hemorrhage is suspected, showing progressively bloodier aliquots and hemosiderin-laden macrophages 5

Critical Management Considerations

Immediate Stabilization

  • Assess respiratory status urgently, as ground glass opacities may represent active alveolar hemorrhage requiring ICU-level care 4, 5
  • Monitor hemoglobin closely for evidence of ongoing pulmonary hemorrhage 4

Treatment Initiation

  • If ANCA-associated vasculitis is confirmed, immediate immunosuppression with high-dose corticosteroids (methylprednisolone 500-1000mg IV daily for 3 days) combined with cyclophosphamide or rituximab is life-saving 4, 1
  • Do not delay treatment pending biopsy results if clinical suspicion is high and patient is deteriorating 1

Common Pitfalls to Avoid

  • Do not attribute syncope solely to vasovagal causes without excluding life-threatening pulmonary or cardiac involvement 4
  • Do not dismiss normal kidney function tests as excluding significant renal disease; proteinuria with unilateral atrophy suggests chronic damage with compensatory function from the contralateral kidney 2, 3
  • Do not delay bronchoscopy beyond 6-8 weeks if ground glass opacities persist, as this may represent organizing pneumonia, infection, or progressive vasculitis requiring different management 5
  • Routine comprehensive laboratory testing has limited utility in syncope evaluation per ACC/AHA guidelines, but targeted testing for systemic disease is essential when clinical features suggest vasculitis 4

References

Research

Acute glomerulonephritis.

Lancet (London, England), 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Persistent Ground Glass Opacity Post-Pneumonia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.